Our Company

Incorporated in 1998, CutisPharma's FIRST® Unit-of-Use Kits franchise has grown in its 17 years of operation from two product offerings to 24 different products with extensive usage across all national pharmacy chains, independent pharmacies, and hospital inpatient/outpatient pharmacies. In 2014, we significantly expanded our operating infrastructure and capabilities with a move into a new state-of-the-art corporate headquarters that includes facilities for warehousing, distribution and manufacturing. CutisPharma continues to aggressively invest in its rich R&D pipeline to continue to bring new products to market, including enhancing the range of portfolio offerings of the FIRST® Unit-of-Use Compounding Kit family as well as the company's most significant transformative effort in its R&D history to now focus on new product approvals via NDA filings with the FDA. The company is currently preparing its first NDA filing for its’ lead pipeline drug, RM-01 and is expanding focus on its pipeline of new drugs.